A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes

Completed · Phase 3

Conditions studied: Diabetes, Diabetes Mellitus, Type 2

In brief

This trial is conducted in the United States of America (USA). The aim of the trial is to compare the safety and efficacy of insulin degludec (IDeg) and insulin glargine (IGlar) with or without OADs (oral anti-diabetic drugs) excluding SUs (sulfonylureas)/glinides in subjects with type 2 diabetes.

Key facts

Study ID

NCT02030600

Run by

Novo Nordisk A/S

People needed

721

Starts

2014-01-06

Expected to finish

2015-12-04

Last updated by the study team

2019-05-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Novo Nordisk Investigational Site — Birmingham, Alabama, United States
• Novo Nordisk Investigational Site — Haleyville, Alabama, United States
• Novo Nordisk Investigational Site — Montgomery, Alabama, United States
• Novo Nordisk Investigational Site — Tuscumbia, Alabama, United States
• Novo Nordisk Investigational Site — Chandler, Arizona, United States
• Novo Nordisk Investigational Site — Phoenix, Arizona, United States
• Novo Nordisk Investigational Site — Tucson, Arizona, United States
• Novo Nordisk Investigational Site — Little Rock, Arkansas, United States
• Novo Nordisk Investigational Site — Costa Mesa, California, United States
• Novo Nordisk Investigational Site — Downey, California, United States
• Novo Nordisk Investigational Site — El Cajon, California, United States
• Novo Nordisk Investigational Site — Fresno, California, United States
• Novo Nordisk Investigational Site — Fresno, California, United States
• Novo Nordisk Investigational Site — Hawaiian Gardens, California, United States
• Novo Nordisk Investigational Site — Huntington Park, California, United States
• Novo Nordisk Investigational Site — Lincoln, California, United States
• Novo Nordisk Investigational Site — Long Beach, California, United States
• Novo Nordisk Investigational Site — Montclair, California, United States
• Novo Nordisk Investigational Site — North Hollywood, California, United States
• Novo Nordisk Investigational Site — Northridge, California, United States
• Novo Nordisk Investigational Site — Pomona, California, United States
• Novo Nordisk Investigational Site — Poway, California, United States
• Novo Nordisk Investigational Site — Rancho Cucamonga, California, United States
• Novo Nordisk Investigational Site — Rialto, California, United States
• Novo Nordisk Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.